Hematology NewsGene therapy regimen for XSCID shows rapid results in newly diagnosed infantsDecember 9, 2017Cellular Therapy
Hematology NewsCyclophosphamide after transplant reduced GVHD in myeloma patientsNovember 20, 2017Multiple MyelomaCellular TherapyLymphoma & Plasma Cell Disorders
Hematology NewsFDA addresses cell-based regenerative medicine in comprehensive new policyNovember 16, 2017Business of MedicinePractice ManagementCellular Therapy
Hematology NewsFDA approves letermovir for CMV prophylaxisNovember 10, 2017Cellular TherapyPatient & Survivor Care
Oncology PracticeAnidulafungin effectively treated invasive pediatric candidiasis in open-label trialOctober 5, 2017PediatricsPatient & Survivor CareCellular Therapy
Oncology PracticeTocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse eventsSeptember 20, 2017Immuno-oncologyImmunotherapyLung CancerCellular Therapy
Hematology NewsOff-the-shelf T cells used to treat viral infections after HSCTAugust 16, 2017Cellular TherapyPatient & Survivor Care
Hematology NewsALLOZITHRO trial: HSCT patients fared worse with azithromycinAugust 8, 2017Cellular TherapyPatient & Survivor Care
Oncology PracticeAlopecia may be permanent in one in four pediatric HSCT patientsAugust 2, 2017PediatricsPatient & Survivor CareCellular Therapy
Hematology NewsIbrutinib becomes first FDA-approved treatment for chronic GVHDAugust 2, 2017Cellular TherapyPatient & Survivor Care
Hematology NewsBone marrow transplantation for epidermolysis bullosa continues to evolveJuly 28, 2017PediatricsRare DiseasesCellular Therapy
Hematology NewsFour drugs better than three for myeloma inductionJuly 25, 2017Multiple MyelomaCellular TherapyLymphoma & Plasma Cell Disorders
Hematology NewsAllele-matching in cord blood transplant yields better survivalJuly 20, 2017Bleeding DisordersCellular TherapyAnemia
Hematology NewsAll FDA panel members go thumbs up for CTL019 in relapsed/refractory childhood ALLJuly 12, 2017ALLCellular TherapyLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Hematology NewsTool indicates fracture risk after HSCTJuly 10, 2017Multiple MyelomaPatient & Survivor CareCellular Therapy
